DK0752425T3 - Peptidligander for den konstante region på immunoglobuliner - Google Patents
Peptidligander for den konstante region på immunoglobulinerInfo
- Publication number
- DK0752425T3 DK0752425T3 DK96201706T DK96201706T DK0752425T3 DK 0752425 T3 DK0752425 T3 DK 0752425T3 DK 96201706 T DK96201706 T DK 96201706T DK 96201706 T DK96201706 T DK 96201706T DK 0752425 T3 DK0752425 T3 DK 0752425T3
- Authority
- DK
- Denmark
- Prior art keywords
- immunoglobulins
- amino acid
- constant region
- peptide
- peptide ligands
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 108060003951 Immunoglobulin Proteins 0.000 title 1
- 102000018358 immunoglobulin Human genes 0.000 title 1
- 229940072221 immunoglobulins Drugs 0.000 title 1
- 239000003446 ligand Substances 0.000 title 1
- 125000000539 amino acid group Chemical group 0.000 abstract 3
- 239000004475 Arginine Substances 0.000 abstract 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 abstract 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 abstract 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N guanidine group Chemical group NC(=N)N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 abstract 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 abstract 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 abstract 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 abstract 1
- 239000004473 Threonine Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000000539 dimer Substances 0.000 abstract 1
- 239000013638 trimer Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0815—Tripeptides with the first amino acid being basic
- C07K5/0817—Tripeptides with the first amino acid being basic the first amino acid being Arg
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
- G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
- G01N33/538—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody by sorbent column, particles or resin strip, i.e. sorbent materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT95MI001328A IT1276761B1 (it) | 1995-06-21 | 1995-06-21 | Peptidi multimerici |
| ITMI960831 IT1282380B1 (it) | 1996-04-29 | 1996-04-29 | Peptide utile come ligando |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0752425T3 true DK0752425T3 (da) | 2000-04-10 |
Family
ID=26331293
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK96201706T DK0752425T3 (da) | 1995-06-21 | 1996-06-19 | Peptidligander for den konstante region på immunoglobuliner |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US5880259A (da) |
| EP (1) | EP0752425B1 (da) |
| JP (1) | JP3811524B2 (da) |
| CN (1) | CN1183155C (da) |
| AT (1) | ATE185147T1 (da) |
| CA (1) | CA2179562C (da) |
| DE (1) | DE69604454T2 (da) |
| DK (1) | DK0752425T3 (da) |
| ES (1) | ES2137620T3 (da) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0752425T3 (da) | 1995-06-21 | 2000-04-10 | Tecnogen Scpa | Peptidligander for den konstante region på immunoglobuliner |
| ITMI962628A1 (it) * | 1996-12-16 | 1998-06-16 | Tecnogen Scpa | Composizione farmaceutica |
| CN1286535C (zh) | 1997-03-25 | 2006-11-29 | 钟渊化学工业株式会社 | 用于消除丙肝病毒的吸附剂、吸附器和吸附方法 |
| US6680376B2 (en) * | 2000-12-08 | 2004-01-20 | Good Biotech Corporation | Process for selectively isolating avian immunoglobulins |
| US6957672B2 (en) * | 2001-07-25 | 2005-10-25 | Imperial Chemical Industries Plc | Method for ensuring that coating compositions have correct color |
| US20050272917A1 (en) * | 2004-05-14 | 2005-12-08 | Hematech, Llc | Methods for immunoglobulin purification |
| US7651647B1 (en) | 2004-07-15 | 2010-01-26 | Pacesetter, Inc. | Method for producing highly conductive battery electrodes |
| ITMI20041569A1 (it) | 2004-07-30 | 2004-10-30 | Tecnogen Scpa | "ligandi peptidici specifici per le immunoglobuline" |
| US7408030B2 (en) * | 2005-01-13 | 2008-08-05 | North Carolina State University | Purification of immunoglobulins using affinity chromatography and peptide ligands |
| ITMI20071119A1 (it) | 2007-06-01 | 2008-12-02 | Tecnogen Spa | Nuovi ligandi sintetici per immunoglobuline e composizioni farmaceutiche che li comprendono |
| BR112018074620A2 (pt) | 2016-06-06 | 2019-03-06 | Medizinische Universität Wien | método para a detecção de um anticorpo de igm específico para um flavivírus em uma amostra |
| CN106279715A (zh) * | 2016-08-30 | 2017-01-04 | 武汉大学 | 一种铜‑肽多孔配位聚合物及其制备方法和应用 |
| CN114585434A (zh) * | 2019-10-23 | 2022-06-03 | 新加坡国立大学 | 用于合成化合物的方法和系统 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5229490A (en) * | 1987-05-06 | 1993-07-20 | The Rockefeller University | Multiple antigen peptide system |
| US5227297A (en) * | 1990-04-17 | 1993-07-13 | Smithkline Beecham Corporation | Affinity purification ligands |
| US5141862A (en) * | 1990-04-17 | 1992-08-25 | Smithkline Beecham Corporation | Method of purifying tpa or plasminogen activator using a tripeptide of the formula: -X-Y-argininal wherein X and Y are selected from the group consisting of pro,phe,trp and tyr |
| DE69126592T2 (de) * | 1990-10-15 | 1998-01-08 | Tecnogen Scpa | Nicht-lineare Peptide, die hydropatisch komplementär zu bekannten Aminosäuresequenzen sind, Verfahren zur Herstellung und Verwendung davon |
| GB9107434D0 (en) * | 1991-04-09 | 1991-05-22 | Medical Res Council | Peptide-based assay |
| JPH07188283A (ja) * | 1991-04-19 | 1995-07-25 | Suetsuna Yoko | 新規なトリペプチドおよびアンジオテンシン変換酵素 阻害剤 |
| US5216126A (en) * | 1991-06-19 | 1993-06-01 | Genentech, Inc. | Receptor polypeptides and their production and uses |
| JPH07508400A (ja) * | 1992-03-03 | 1995-09-21 | ザ ソーク インスティチュート フォア バイオロジカル スタディーズ | 受容体のインターナライゼーション・シグナル |
| WO1995006125A1 (en) * | 1993-08-23 | 1995-03-02 | Applied Immune Sciences, Inc. | CHIMERIC RECEPTOR CONTAINING ONE IgG BINDING DOMAIN OF BOTH PROTEIN A AND PROTEIN G |
| DK0752425T3 (da) | 1995-06-21 | 2000-04-10 | Tecnogen Scpa | Peptidligander for den konstante region på immunoglobuliner |
-
1996
- 1996-06-19 DK DK96201706T patent/DK0752425T3/da active
- 1996-06-19 EP EP96201706A patent/EP0752425B1/en not_active Expired - Lifetime
- 1996-06-19 AT AT96201706T patent/ATE185147T1/de not_active IP Right Cessation
- 1996-06-19 DE DE69604454T patent/DE69604454T2/de not_active Expired - Fee Related
- 1996-06-19 ES ES96201706T patent/ES2137620T3/es not_active Expired - Lifetime
- 1996-06-20 US US08/670,207 patent/US5880259A/en not_active Expired - Lifetime
- 1996-06-20 CA CA002179562A patent/CA2179562C/en not_active Expired - Fee Related
- 1996-06-21 JP JP16180096A patent/JP3811524B2/ja not_active Expired - Fee Related
- 1996-06-21 CN CNB961109920A patent/CN1183155C/zh not_active Expired - Fee Related
-
1998
- 1998-12-03 US US09/204,164 patent/US6207807B1/en not_active Expired - Fee Related
-
2000
- 2000-10-18 US US09/691,852 patent/US6566077B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1145369A (zh) | 1997-03-19 |
| DE69604454D1 (de) | 1999-11-04 |
| US6566077B1 (en) | 2003-05-20 |
| DE69604454T2 (de) | 2000-03-02 |
| EP0752425A3 (en) | 1997-07-09 |
| US5880259A (en) | 1999-03-09 |
| ES2137620T3 (es) | 1999-12-16 |
| ATE185147T1 (de) | 1999-10-15 |
| CA2179562C (en) | 2007-12-18 |
| US6207807B1 (en) | 2001-03-27 |
| CN1183155C (zh) | 2005-01-05 |
| JPH0920795A (ja) | 1997-01-21 |
| EP0752425B1 (en) | 1999-09-29 |
| CA2179562A1 (en) | 1996-12-22 |
| JP3811524B2 (ja) | 2006-08-23 |
| EP0752425A2 (en) | 1997-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0752425T3 (da) | Peptidligander for den konstante region på immunoglobuliner | |
| DE69408666D1 (de) | Risperidon pamoate | |
| MY137301A (en) | Peptide analogs as irreversible interleukin-1b protease inhibitors | |
| EP0528858A4 (en) | Inhibitors of dipeptidyl-aminopeptidase type iv | |
| EP0810209A3 (en) | Alpha - and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors | |
| ZA967379B (en) | Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid compounds and derivatives thereof. | |
| CA2011294A1 (en) | Carbonylation catalyst system | |
| ATE69239T1 (de) | Oligopeptidylnitrilderivate, diese enthaltende mittel, verfahren zu ihrer herstellung und ihre verwendung. | |
| DK372083A (da) | Fremgangsmaade til fremstilling af peptidderivater, der er inhibitorer overfor proteasesyrer | |
| TR200001740T2 (tr) | Mikrobisidal ve bitkiye bağışıklık kazandırıcı aktiviteleri olan tiyazol-türevleri | |
| KR920014778A (ko) | 헤테로사이클릭 하이드록실아민 | |
| ES2081817T3 (es) | Polipeptido con secuencias principales repetidas que se fijan en la celula. | |
| CA2010035A1 (en) | Proline derivatives | |
| ES2001697A6 (es) | Procedimiento para preparar 2-aminopurinas sustituidas en posiciones 6 y 9 | |
| CA1264899C (en) | SYNTHESIS OF PEPTIDES USING THIOXANTHYLMETHYLOXYCARBONYL DIOXIDES | |
| GB9226144D0 (en) | Further improvements relating to the radiolabelling of proteins | |
| DE69715910D1 (de) | Pharmazeutische zusammensetzung enthaltend peptide für die inhibierung der immunoglobulin-rezeptor interaktion | |
| ATE80381T1 (de) | Verfahren zur herstellung von n,n'-bis(3aminophenyl)harnstoffen. | |
| ES8206506A1 (es) | Procedimiento de preparacion de amino alcosi furanos o tio- fenos. | |
| ATE70454T1 (de) | Vincristin enthaltendes produkt. | |
| ATE94168T1 (de) | Peptide. | |
| DE69525169D1 (de) | Verfahren zur herstellung von n-carboxyanhydridaminosäuren aus n-(n'-nitrosocarbamoyl)-aminosäuren | |
| MX173930B (es) | Procedimiento para preparar compuestos de 1h-benzotriazol-hidroxietil -sulfona n1 sustituidos y su empleo para la preparacion de colorantes | |
| KR970701732A (ko) | 펩신 방출을 억제하기 위한 펩티드(Peptides Inhibiting the Release of Pepsin) | |
| RU96118282A (ru) | Пептиды для ингибирования высвобождения пепсина |